STOCKWATCH
·
Pharmaceuticals
Investment12 Nov 2025, 12:53 pm

Dishman Carbogen Amcis' Subsidiary Successfully Refinances and Enhances Credit Facilities

AI Summary

Dishman Carbogen Amcis Ltd. announced that its wholly-owned subsidiary, CARBOGEN AMCIS Holding AG., has successfully refinanced and enhanced its syndicated credit facilities. The refinancing provides access to an additional CHF 40 million, with an accordion feature enabling a further CHF 30 million, bringing the total credit capacity to CHF 162,235,250 and EUR 50,000,000. This move supports the company's future growth and its vision-based strategy that focuses on innovation, efficiency, environment, and safety. The transaction reflects the strength of CARBOGEN AMCIS’s long-term relationships with its banking partners and their confidence in the Group’s business strategy and future growth trajectory.

Key Highlights

  • Dishman Carbogen Amcis' subsidiary, CARBOGEN AMCIS, has successfully refinanced and enhanced its syndicated credit facilities.
  • The refinancing provides access to an additional CHF 40 million, with an accordion feature enabling a further CHF 30 million.
  • This move supports the company's future growth and its vision-based strategy focusing on innovation, efficiency, environment, and safety.
  • The transaction reflects the strength of CARBOGEN AMCIS’s long-term relationships with its banking partners.
  • The enhanced credit facility will support the consistency and success of CARBOGEN AMCIS's initiatives.
DCAL
Pharmaceuticals
Dishman Carbogen Amcis Ltd

Price Impact